Fig. 3.
Cohort studies generating ante- and post-mortem biospecimens which are used to generate multi-layered omics data. These data feed a systems biology computation pipeline for therapeutic target nomination. There are two stages of functional validation, one with targeted proteomics using brain tissue from the same cases and the other with a variety of high throughput ex vivo models. High value targets will then move to small molecule drug screen and eventual drug selection.